AMANDA HUBER: Open Payments
NPI 1316184195 · JAMESTOWN, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$180 in 11 payments from 9 companies in 2025. Trend: 2023 $278 · 2024 $180 · 2025 $180
Food & beverage: $180
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $33 |
| Dexcom, Inc. | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| MIMEDX Group, Inc. | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: Dexcom G6 Transmitter, CAMZYOS, OTEZLA, TRINTELLIX, Ozempic, EVENITY, OPSUMIT, Auvelity.
Industry payments across ND — which companies pay providers there.
